Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/688073 stock hub

SHA/688073 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/688073is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
5.1B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/688073
In the news

Latest news · SHA/688073

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.4
P25 17.1P50 24.2P75 37.8
Trailing P/E30.6
P25 23.5P50 41.3P75 83.2
ROE8.1
P25 -0.9P50 4.1P75 8.8
ROIC18.3
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/688073 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
217
Groups with data
11
Currency
CNY
Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
129
Employees Change
-609%
Employees Change Percent
-82.52
Enterprise value
CNY 4.2B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE100005NV3
Last refreshed
2026-05-10
Market cap
CNY 5.1B
Price
CNY 59.24
Price currency
CNY
Rev Per Employee
1,830,234.16x
Sector
Healthcare
Sic
2833
Symbol
sha/688073
Website
https://www.bidepharmatech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
3.29%
EV Earnings
24.78x
EV/EBIT
15.5x
EV/EBITDA
14.48x
EV/FCF
117.12x
EV/Sales
3.08x
FCF yield
0.7%
Forward P/E
22.35x
P/B ratio
2.43x
P/E ratio
30.64x
P/S ratio
3.78x
PE Ratio3 Y
37.38x
PE Ratio5 Y
38.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
19.88%
EBITDA Margin
21.02%
FCF margin
2.63%
Gross margin
45.62%
Gross Profit
CNY 616.2M
Gross Profit Growth
27.12%
Gross Profit Growth Q
20.26%
Gross Profit Growth3 Y
16.69%
Gross Profit Growth5 Y
46.48%
Net Income
CNY 167.9M
Net Income Growth
37.55%
Net Income Growth Q
52.57%
Net Income Growth3 Y
2.16%
Pretax Margin
15.8%
Profit Margin
12.43%
Profit Per Employee
CNY 227,474
ROA
6.44
Roa5y
5.33
ROCE
12.06
ROE
8.12
Roe5y
9.76
ROIC
18.35
Roic5y
17.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr1y
44.38%
Cagr3y
-10.96%
EPS Growth
41.08
EPS Growth Q
58.82
EPS Growth3 Y
-0.96
FCF Growth
17.3%
FCF Growth Q
509.57%
FCF Growth3 Y
0.69%
OCF Growth
-48.26%
OCF Growth Q
455.63%
OCF Growth3 Y
-6.19%
Revenue Growth
18.93x
Revenue Growth Q
9.08x
Revenue Growth3 Y
14.1x
Revenue Growth5 Y
52.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CNY 0.52
Assets
CNY 2.5B
Cash
CNY 1.1B
Current Assets
CNY 2.3B
Current Liabilities
CNY 315.9M
Debt
CNY 135.4M
Debt EBITDA
CNY 0.47
Debt Equity
CNY 0.06
Debt FCF
CNY 3.81
Equity
CNY 2.1B
Liabilities
CNY 442.2M
Long Term Assets
CNY 195.8M
Long Term Liabilities
CNY 126.3M
Net Cash
CNY 943.1M
Net Cash By Market Cap
CNY 18.48
Net Cash Growth
205.24%
Net Debt EBITDA
CNY -3.32
Net Debt Equity
CNY -0.45
Net Debt FCF
CNY -26.55
Tangible Book Value
CNY 2.1B
Tangible Book Value Per Share
CNY 24.07
WACC
7.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
7.43
Inventory Turnover
0.83
Net Working Capital
CNY 968.5M
Quick ratio
4.28
Working Capital
CNY 2B
Working Capital Turnover
CNY 0.86

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
2.5%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
CNY 0.9
Dividend Years
3
Dividend Yield
1.52%
Ex Div Date
2025-06-09
Last Dividend
CNY 0.9
Payout Frequency
Annual
Payout Ratio
46.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
44.35%
200-day SMA
64.67
3Y total return
-29.41%
50-day SMA
57.73
50-day SMA vs 200-day SMA
50under200
All Time High
114.1
All Time High Change
-48.06%
All Time High Date
2023-02-17
All Time Low
28.5
All Time Low Change
107.86%
All Time Low Date
2024-07-04
ATR
3.03
Beta
0.69
Beta1y
0.04
Beta2y
0.59
Ch YTD
-2.96
High
61.2
High52
82.88
High52 Date
2025-10-29
High52ch
-28.52%
Low
58.98
Low52
40.81
Low52 Date
2025-05-19
Low52ch
45.16%
Ma50ch
2.62%
Price vs 200-day SMA
-8.4%
RSI
49.76
RSI Monthly
51.03
RSI Weekly
47.38
Sharpe ratio
0.97x
Sortino ratio
1.68
Total Return
4.02%
Tr YTD
-2.96
Tr1m
1.89%
Tr1w
-3.85%
Tr3m
-3.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
CNY 268.5M
Operating Income Growth
50.54
Operating Income Growth Q
60.99
Operating Income Growth3 Y
21.01
Operating margin
19.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
31,110,548%
Net Borrowing
-168,425,119
Shares Insiders
51.45%
Shares Institutions
19.85%
Shares Out
86,152,776
Shares Qo Q
-2.18%
Shares Yo Y
-2.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
CNY 35.5M
Average Volume
1,718,691.7x
Bv Per Share
24.22
CAPEX
CNY -25.1M
Ch1m
1.89
Ch1w
-3.85
Ch1y
41.45
Ch3m
-3.75
Ch3y
-33.65
Ch6m
-16.7
Change
-3.06%
Change From Open
-3.2
Close
61.11
Days Gap
0.15
Depreciation Amortization
15,385,975
Dollar Volume
112,356,538.9
Earnings Date
2026-04-23
EBIT
CNY 268.5M
EBITDA
CNY 283.9M
EPS
CNY 1.93
F Score
6
FCF
CNY 35.5M
FCF EV Yield
0.85x
FCF Per Share
CNY 0.41
Financing CF
-329,655,811
Fiscal Year End
December
Founded
2,007
Goodwill
7,556,746
Graham Number
32.45742
Graham Upside
-45.21
Income Tax
CNY 45.6M
Investing CF
574,417,167
Is Primary Listing
1
Last Earnings Date
2026-04-23
Last Report Date
2026-03-31
Last Split Date
2023-05-25
Last Split Type
Forward
Lynch Fair Value
CNY 9.67
Lynch Upside
-83.68
Ma150
65.5
Ma150ch
-9.55%
Ma20
60.13
Ma20ch
-1.48%
Net CF
285,276,231
Next Earnings Date
2026-08-06
Open
61.2
P FCF Ratio
143.7
P OCF Ratio
84.14
Payment Date
2025-06-09
Position In Range
11.71
Ppne
141,341,766
Price Date
2026-05-08
Price EBITDA
CNY 17.98
Ptbv Ratio
2.44
Relative Volume
1.1x
Revenue
1,350,712,812x
Tax By Revenue
3.37x
Tax Rate
21.35%
Tr6m
-16.7%
Volume
1,896,633
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHA/688073 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.5%
$0.90 annual per share
Payout ratio
+46.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
+4.0%
Next ex-dividend date: 2025-06-09
Performance

SHA/688073 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+44.3%
S&P 500 1Y: n/a
3Y total return
-29.4%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHA/688073?

Insider, institutional, and short-interest positioning.

Institutional ownership
+19.9%
Share of float held by funds and institutions
Insider ownership
+51.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.5%
Negative means the company is buying back shares.
Technical

SHA/688073 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.8
Neutral momentum band
Price vs 200-day MA
-8.4%
50/200-day relationship not available
Beta (5Y)
0.69
Less volatile than the market
Sharpe ratio
0.97
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/688073

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688073 stock rating?

sha/688073 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688073 analysis?

The full report lives at /stocks/sha/688073/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688073?

The latest report frames sha/688073 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688073 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

sha/688073 stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA